Skip to main content

Univ. of Washington researchers to test psilocybin in healthcare workers affected by pandemic

By GeekWire
| December 06, 2021

Can psilocybin help relieve the mental health burden of clinicians affected by the COVID-19 pandemic? That’s a question University of Washington researchers aim to address in a new clinical trial testing the psychedelic drug in combination with psychotherapy.

Tagged Under:

Most Popular

#1

The signs patients have the delta variant are different than original COVID-19

Cough, fever, and shortness of breath are common COVID-19 symptoms. Sinus congestion, runny nose and sore throat are symptoms of becoming infected with the delta variant. Sneezing more than usual...

#2

To 'Disrupt' the COVID-19 Virus, Gargle and Rinse!

An over-the-counter mouthwash could slow the spread of the virus. ...

#3

Fact check: Hospitals get paid more if patients listed as COVID-19, on ventilators

Sen. Scott Jensen, R-Minn., a physician in Minnesota, was interviewed by "The Ingraham Angle" host Laura Ingraham on April 8 on Fox News and claimed hospitals get paid more if Medicare patients are...

#4

CDC Announces New ICD-10-CM Codes for COVID-19-related Conditions

All six new codes will be effective January 1, 2021. ...

#5

Does It Make Sense To Delay Children's Vaccines?

Delaying vaccines is risky. Many pediatricians say a more gradual approach to vaccinations is better than no vaccinations, but they offer hard advice to parents considering it. ...